...
首页> 外文期刊>Respiratory Research >Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses
【24h】

Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses

机译:HSA-MicroRNA-204-5P的下调和非小细胞肺癌中潜在调节网络的鉴定:RT-QPCR,生物信息 - 和Meta分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND:Pulmonary malignant neoplasms have a high worldwide morbidity and mortality, so the study of these malignancies using microRNAs (miRNAs) has attracted great interest and enthusiasm. The aim of this study was to determine the clinical effect of hsa-microRNA-204-5p (miR-204-5p) and its underlying molecular mechanisms in non-small cell lung cancer (NSCLC).METHODS:Expression of miR-204-5p was investigated by real-time quantitative PCR (RT-qPCR). After data mining from public online repositories, several integrative assessment methods, including receiver operating characteristic (ROC) curves, hazard ratios (HR) with 95% confidence intervals (95% CI), and comprehensive meta-analyses, were conducted to explore the expression and clinical utility of miR-204-5p. The potential objects regulated and controlled by miR-204-5p in the course of NSCLC were identified by estimated target prediction and analysis. The regulatory network of miR-204-5p, with its target genes and transcription factors (TFs), was structured from database evidence and literature references.RESULTS:The expression of miR-204-5p was downregulated in NSCLC, and the downtrend was related to gender, histological type, vascular invasion, tumor size, clinicopathologic grade and lymph node metastasis (P0.05). MiR-204-5p was useful in prognosis, but was deemed unsuitable at present as an auxiliary diagnostic or prognostic risk factor for NSCLC due to the lack of statistical significance in meta-analyses and absence of large-scale investigations. Gene enrichment and annotation analyses identified miR-204-5p candidate targets that took part in various genetic activities and biological functions. The predicted TFs, like MAX, MYC, and RUNX1, interfered in regulatory networks involving miR-204-5p and its predicted hub genes, though a modulatory loop or axis of the miRNA-TF-gene that was out of range with shortage in database prediction, experimental proof and literature confirmation.CONCLUSIONS:The frequently observed decrease in miR-204-5p was helpful for NSCLC diagnosis. The estimated target genes and TFs contributed to the anti-oncogene effects of miR-204-5p.
机译:背景:肺部恶性肿瘤在全球性的发病率和死亡率高,因此使用Micrornas(MiRNA)的这些恶性肿瘤的研究引起了极大的兴趣和热情。本研究的目的是确定HSA-MicroRNA-204-5P(MIR-204-5P)的临床效果及其在非小细胞肺癌(NSCLC)中的潜在分子机制。方法:MIR-204-的表达通过实时定量PCR(RT-QPCR)研究了5P。在从公共在线存储库进行数据挖掘后,进行了几种综合评估方法,包括接收器操作特征(ROC)曲线,危险比(HR)具有95%置信区间(95%CI)和全面的荟萃分析,以探索表达式和MiR-204-5P的临床效用。通过估计的目标预测和分析鉴定了在NSCLC过程中由miR-204-5p调节和控制的潜在物体。 MiR-204-5P的调控网络,其目标基因和转录因子(TFS)是由数据库证据和文献参考构成的。结果:MIR-204-5P的表达在NSCLC中下调,下降趋势有关对性别,组织学型,血管侵袭,肿瘤大小,临床病变等级和淋巴结转移(P <0.05)。 miR-204-5p可用于预后,但由于缺乏Meta分析和缺乏大规模调查,目前被视为NSCLC的辅助诊断或预后危险因素。基因浓缩和注释分析确定了参与各种遗传活动和生物学功能的MIR-204-5P候选目标。预测的TFS,如MAX,MYC和RUNX1,干扰了涉及MIR-204-5P及其预测的枢纽基因的调控网络,但在数据库短缺范围内的miRNA-TF-基因的调制环或轴预测,实验证明和文献证实。结论:MIR-204-5P的经常观察到的降低有助于NSCLC诊断。估计的靶基因和TFS有助于miR-204-5p的抗癌基因作用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号